Kohanbash Gary, Frederico Stephen C, Raphael Itay
Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
J Immunother Cancer. 2025 Mar 18;13(3):e011581. doi: 10.1136/jitc-2025-011581.
Melanoma brain metastases (BMs) pose a significant clinical challenge. This commentary highlights the emerging understanding of the mechanisms behind immune-checkpoint blockade (ICB) efficacy in melanoma BMs. Specifically, we focus on a recent study by Fife , which revealed a non-canonical role for natural killer (NK) cells in shaping the tumor microenvironment following ICB therapy against melanoma BMs. Instead of direct tumor cell killing, this study demonstrates that ICB triggers NK cell chemokine release, CD8 T cell recruitment and enhanced antitumor immunity. The findings from this study highlight that the ICB mechanisms of action are complex and extend beyond the direct interference of inhibitor receptor-ligand interactions between cytotoxic CD8 T cells and tumor cells.
黑色素瘤脑转移（BMs）构成了重大的临床挑战。本评论重点阐述了对免疫检查点阻断（ICB）治疗黑色素瘤脑转移疗效背后机制的新认识。具体而言，我们关注了法伊夫最近的一项研究，该研究揭示了自然杀伤（NK）细胞在ICB治疗黑色素瘤脑转移后塑造肿瘤微环境中的非典型作用。该研究表明，ICB并非直接杀伤肿瘤细胞，而是触发NK细胞趋化因子释放、CD8 T细胞募集并增强抗肿瘤免疫力。这项研究的结果突出表明，ICB的作用机制很复杂，且不仅仅局限于细胞毒性CD8 T细胞与肿瘤细胞之间抑制剂受体 - 配体相互作用的直接干扰。
